Controlled (balanced) diabetes-Uncontrolled Posts on Medivizor
Navigation Menu

Controlled (balanced) diabetes-Uncontrolled Posts on Medivizor

Looking for patients with poorly controlled type 2 diabetes to try the EndoBarrier System

Posted by on Sep 30, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study is investigating the safety and effectiveness of the EndoBarrier system for patients with poorly controlled type 2 diabetes (T2D) and obesity. The main outcome to be measured will be the change in blood glucose levels. This trial is recruiting in multiple locations across the United States. The details Bariatric surgery is the...

Read More

Type 1 diabetes and risk factors for heart disease

Posted by on Jul 28, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study wanted to find out what factors put young people with type 1 diabetes at risk of developing impaired blood flow or heart issues. The study found that poor control of blood sugars and traditional risk factors for heart disease, such as high blood pressure and obesity, were associated with an increased risk of blood flow issues in...

Read More

Efficacy and safety of basal-bolus insulin vs glp-1 receptor agonist plus basal insulin in patients with uncontrolled type 2 diabetes

Posted by on Jun 27, 2019 in Diabetes mellitus | 0 comments

In a nutshell This article compared the safety and effectiveness of insulin detemir (Levemir) plus liraglutide (Victoza) vs insulin detemir plus insulin aspart (Novolog) in the management of type 2 diabetes (T2D). The authors concluded that detemir plus liraglutide is a safe and more...

Read More

A fixed combination of lixisenatide and insulin in the treatment of type 2 diabetes

Posted by on Mar 29, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to evaluate the safety and effectiveness of a fixed combination of lixisenatide (Lyxumia) and insulin glargine (Lantus) for the treatment of type 2 diabetes (T2D) in older patients. The main finding of the study was that a lixisenatide/insulin glargine (iGlarLixi; Soliqua) combination improved blood...

Read More

Looking for patients with type 2 diabetes to test new treatment efpeglenatide

Posted by on Feb 24, 2019 in Diabetes mellitus | 0 comments

In a nutshell This trial is examining the safety and effectiveness of efpeglenatide versus dulaglutide in patients with poorly controlled type 2 diabetes (T2D) who are on metformin. The main outcome to be measured will be a change in HbA1c (blood test measuring average blood glucose over the past 3 months). This trial is being conducted in the United...

Read More

How safe and effective is ertugliflozin in patients with type 2 diabetes?

Posted by on Feb 9, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to evaluate how safe and effective ertugliflozin (Steglatro) is in patients with type 2 diabetes (T2D) that is not controlled well with metformin (Glucophage). The study found that ertugliflozin is safe and improved blood glucose control, body weight, and blood pressure in these patients. Some background...

Read More

Is IDegLira a suitable treatment for patients with uncontrolled type 2 diabetes?

Posted by on Mar 5, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the suitability of IDegLira for treating patients with uncontrolled type 2 diabetes. The authors concluded that using IDegLira was safe and effective at reducing blood-sugar levels.  Some background IDegLira is an injectable, fixed-ratio combination of basal insulin (degludec) and a glucagon-like peptide-1...

Read More

Investigating a combination of ertugliflozin and sitagliptin in people with type 2 diabetes

Posted by on Jan 26, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the effectiveness and safety of ertugliflozin (Steglatro) plus sitagliptin (Januvia), compared to either drug used alone, in people with type 2 diabetes (T2D). It was determined that the combination was better at controlling blood glucose levels, without increasing the risk of side effects. Some background...

Read More